The question
Are accumulated mutations the primary cause that starts and sustains cancer?
This is the specific idea being tested.
The Hypothesis Critic · A guide for everyone
Somatic Mutation Theory of Cancer
Are accumulated mutations the primary cause that starts and sustains cancer?
What you need to knowMutations can cause cancer in defined settings, but including tissue conditions explains more of the evidence.Relative explanatory fit: Alternative ranked ahead
Why the alternative fits better: Genetic changes, cell type, surroundings and gene regulation jointly affect cancer behaviour.
Review summary
Claim assessed: Sequential somatic driver mutations are the primary initiating and sustaining cause of cancer.
Finding: The preregistered scope-matched SC3 gate returns Ε: causal validity with explicit context limits. Driver identification reaches Ζ and defined initiation/maintenance dependencies reach Η through endogenous autochthonous genetics, restoration/rechallenge, human genomic natural history and genotype-selected hard clinical outcomes. The set is not re-capped by culture or xenograft limitations. Broad primacy requires a representative comparison of mutation, tissue and cell-state causation across initiation, maintenance and relapse; that burden is not established by genetic relevance alone. Benign driver clones challenge sufficiency, not the strong causal genetic evidence.
Key points
- SC1: Recurrent somatic driver mutations can be distinguished from passengers in specific cancers. — HSEF Ζ, Moderate confidence.
- SC2: Driver mutations are causal dependencies for initiation or maintenance in defined cancers. — HSEF Η, Moderate confidence.
- SC3: Sequential somatic driver mutations are the dominant initiating and sustaining cause across cancer. — HSEF Ε, Moderate confidence.
Verdict and review details
- Evidence grade
- HSEF Ε — Context-specific causality established
- Confidence
- Moderate
- Framework
- HSEF v5.3
- Review date
- Literature cutoff
- Published
- Review attribution (recorded)
- Codex
Evidence scope: 70 primary reports; literature cutoff 2026-10-06; source examination UTC date 2026-10-06; bounded critical review, not exhaustive systematic review.
The grade applies to the stated claim. Model rankings and individual subclaim grades remain separate from the overall causal-evidence grade.
Full scientific assessment and references · Scorecard (JSON) · Review source (Markdown)
The result at a glance
Mutations can cause cancer in defined settings, but including tissue conditions explains more of the evidence.
Read the labels in this illustration
THE MAIN FINDING Mutations can cause cancer in defined settings, but including tissue conditions explains more of the evidence. The idea Are accumulated mutations the primary cause that starts and sustains cancer? Accumulated mutations Cancer starts and persists Proposed chain — plausible, not established What fits better Best fit in this review Mutations and tissue conditions interact The same mutation, different surroundings Tumour cross-section Cancer cells Immune cells Mutated cell Cell type Surroundings Gene regulation Immune signals What remains uncertain How tissue context changes what a mutation does Which tissue signals matter most for cancer behaviour Whether correcting mutations alone reverses malignancy Evidence comes from cells, animals, and people — each setting carries different weight. Genetic changes, cell type, surroundings and gene regulation jointly affect cancer behaviour. Conceptual illustration
Best fit in this review
Mutations and tissue conditions interact
Genetic changes, cell type, surroundings and gene regulation jointly affect cancer behaviour.
Evidence for the stated claim
Causal in a specific setting
A higher rank means a better fit to the evidence in this comparison. It does not prove every part of the leading explanation.
Which explanation fits?
Another explanation fits better.
A separate question from the causal evidence grade
How does this explanation compare with alternatives?
Alternative ranked aheadThe reviewed hypothesis ranks 2 among 5 models compared; 1 alternative model(s) hold first rank for this stated claim.
Claim under review: rank 2 among 5 compared models.
Leading explanation: Integrated mutation–tissue model.
Position in this comparison: Next after leading rank.
The causal grade asks how well the stated causal claim is established. This comparison asks which of the assessed explanations fits the reviewed findings better. A leading explanation can remain unproven. Models can overlap or include the tested mechanism; an alternative ahead does not make that mechanism irrelevant. These ordinal ranks apply within this review; they do not measure the size of a difference or rank scientific strength across topics.
Read the labels in this illustration
TWO EXPLANATIONS, COMPARED A · The idea under review Are accumulated mutations the primary cause that starts and sustains cancer? Proposed chain Accumulated mutations Cancer starts and persists Each arrow is a proposal, not a proven step. Genetic changes, cell type, surroundings and gene regulation jointly affect cancer behaviour. B · Leading explanation Another explanation fits better Mutations and tissue conditions interact Mutation alone Mutation inside tissue: more is explained A better fit is not proof of every part of the explanation. These explanations can overlap. Conceptual illustration
Idea being tested · rank 2
Are accumulated mutations the primary cause that starts and sustains cancer?
Causal in a specific setting for the stated claim.
Best fit in this review · rank 1
Mutations and tissue conditions interact
Genetic changes, cell type, surroundings and gene regulation jointly affect cancer behaviour.
These explanations can overlap. Ranking their fit to the evidence is separate from deciding how firmly a cause has been established.
See all the explanations compared
Rank 1: Integrated mutation–tissue model — Genetic lesions, lineage, niche and regulatory state jointly determine specified cancer behavior.
Rank 2: Somatic mutation primacy — Sequential somatic drivers dominate cancer initiation and maintenance across cancers.
Rank 3: Nongenetic malignant states — Chromatin and differentiation memory can initiate or sustain malignant/tolerant states in specified contexts.
Rank 4: Chromosomal instability first — Chromosome instability can initiate or facilitate escape in defined models.
Rank 5: Tissue organization field theory — Tissue disorganization is the primary initiating and sustaining cause across cancers.
What this means
?
Causal in a specific setting
Mutations can cause cancer in defined settings, but including tissue conditions explains more of the evidence.
Evidence rating: Ε · Moderate confidence. How the evidence was assessed.
The important distinction
Genetic changes, cell type, surroundings and gene regulation jointly affect cancer behaviour.
Health and treatment
This is an assessment of a causal explanation, not proof that a particular supplement, diet, test, or treatment improves health. A treatment claim needs studies that test the intervention in people and measure meaningful benefits and harms. These findings can help frame research and informed clinical questions, but they do not identify what is right for one person.
From an idea to an explanation
Seeing two things together does not prove one causes the other.
What is observed?
Look for the proposed factor and the outcome, in the people or systems covered by the claim.
What else explains it?
Mutations and tissue conditions interact. Genetic changes, cell type, surroundings and gene regulation jointly affect cancer behaviour.
What test tells them apart?
Correct mutations and change surrounding tissue separately and together, tracking malignant behaviour.
Key questions
The key parts of the idea
These illustrations show the key questions tested in the review. They are conceptual drawings, not microscope images or experimental results.
What to test next
What evidence would make the answer clearer?
Read the labels in this illustration
WHAT WOULD MAKE THE ANSWER CLEARER A research question Correct mutations and change surrounding tissue separately and together, tracking malignant behaviour. then then Change the proposed cause Proposed test Mutations corrected; tissue changed separately and together Mutations corrected only Tissue changed only Both changed Neither — control Malignant behaviour is tracked in each arm. Measure the relevant outcome Proposed test Malignant behaviour Mutation status Tissue state Measured in each arm. Check the result independently Proposed test First team measures Second team repeats An independent check of the result. Same measures, fresh eyes — no shared data until the end. This storyboard shows the logic of a test. It does not show a result. The question is which changes come first — and which ones follow. Conceptual illustration
A useful next question
Correct mutations and change surrounding tissue separately and together, tracking malignant behaviour.
Change the proposed cause
Check that the intended change really happened.
Measure the relevant outcome
Allow for other factors and compare with suitable controls.
Check whether it holds up
Look for independent confirmation and the limits of the effect.
These are questions for research, not a claim that the proposed studies have already succeeded.
Read the scientific study designs
Proposed tests: 1 test design(s) are registered in the scorecard.
In plain terms, researchers would change the proposed cause, check that it changed as intended, then measure a meaningful outcome while controlling plausible alternatives. The result should be able to support or count against the claim—not only show that a pathway exists.
Experiment 1: Registered boundary experiment
Study design: Across predeclared representative histologies, use lineage-resolved native cancers with selective driver correction/restoration and factorial niche/chromatin perturbations, preserving viability and measuring both early initiation and established maintenance/relapse.
What would be measured: Native malignant incidence, longitudinal tumor burden, lineage persistence, metastasis, survival and recurrence with allele-sensitive genome/state monitoring
Important controls: Matched passenger editing, inactive perturbation, normal mutant clones, unchanged baseline viability, tissue lineage and restoration of the specific driver versus matched state rescue
Result that would support the claim: Driver loss/correction suppresses initiation and sustained malignancy across contexts, matched restoration rescues it, and residual tissue/state effects account for only bounded exceptions
Result that would count against it: Verified driver correction leaves sustained malignancy in representative native contexts, or genotype-matched initiation depends dominantly on a separable tissue/state perturbation despite the same genetic state
Explore the evidence
Read the complete scientific review.
Follow the studies, detailed comparisons and evidence ratings behind this guide.
Open the scientific review →